로딩 중…
지수 로딩 중…
한국비티비
219750· KOSDAQ· Health Care· Health Care Equipment & Services
₩1,630-0.37%
2026-09-18
Financials
Valuation Metrics
한국비티비's Market Cap is ₩213B. At end of 2025 it was ₩565B. Ranked #2299 of 2,421 in KR market (top 95%), #1531 of 1,640 on KOSDAQ (top 93%), #92 of 96 in Health Care Equipment & Services (top 96%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 21.33B KRW | KR#2,299/2,421 Sec#92/96 |
| Revenue | 26.92B KRW | KR#2,068/2,421 Sec#69/96 |
| Net Income | -7.97B KRW | KR—/2,421 Sec—/96 |
| Total Assets | 39.71B KRW | KR#2,284/2,421 Sec#81/96 |
| Net Assets | 19.76B KRW | KR#2,290/2,421 Sec#87/96 |
| Employees | 97 | KR#1,660/2,421 Sec#61/96 |
| Value | ||
| P/B | 1.08x | KR#1,534/2,421 Sec#47/96 |
| P/S | 0.79x | KR#1,234/2,421 Sec#19/96 |
| FCF Yield | -28.64% | KR—/2,421 Sec—/96 |
| Profitability | ||
| ROE | -40.35% | KR#2,243/2,421 Sec#81/96 |
| ROA | -20.08% | KR#2,243/2,421 Sec#78/96 |
| Op. Margin | -14.11% | KR#2,057/2,421 Sec#67/96 |
| Revenue Growth | -21.95% | KR#2,153/2,421 Sec#89/96 |
| Earnings Growth | -7871.53% | KR#1,351/2,421 Sec#49/96 |
| Financial Health | ||
| Debt Ratio | 100.95% | KR#1,564/2,421 Sec#79/96 |
| Total Debt | 13.00B KRW | KR#1,539/2,421 Sec#47/96 |
| FCF | -6.11B KRW | KR#1,555/2,421 Sec#52/96 |
| Cash | 2.79B KRW | KR#2,181/2,421 Sec#89/96 |
| Current Ratio | 0.85x | KR#1,893/2,421 Sec#85/96 |
| Performance | ||
| 1Y Return | -69.01% | KR#2,292/2,421 Sec#91/96 |
| 1M Return | -2.45% | KR#1,517/2,421 Sec#49/96 |
| From 52W High | -72.26% | KR#2,240/2,421 Sec#86/96 |
| 1Y MDD | -71.43% | KR#2,045/2,421 Sec#76/96 |
| Trading | ||
| Volume | 1,028 shares | KR#2,324/2,421 Sec#93/96 |
| Trading Value | 1.7M KRW | KR#2,370/2,421 Sec#93/96 |
| Foreign Own. | 0.00% | KR—/2,421 Sec—/96 |
| Per Share | ||
| EPS | -609 KRW | KR—/2,421 Sec—/96 |
| BPS | 1,510 KRW | KR#2,192/2,421 Sec#79/96 |
Company Info
동사는 1999년 설립되어 안티에이징 미용기기 등을 생산·판매하며 2024년 동인바이오텍을 흡수합병해 사명을 변경함. 의료기기사업과 바이오사업을 구분해 뷰티 의료기기 개발·제조·판매와 생명공학 연구용 시약 및 바이오 유통사업을 하고 있음. 동사는 해외 유통 노하우로 55개국 285개 네트워크를 구축하며 국내 1,350개 대학·연구시설·병원에 유통·서비스 제공하고 있음. 한국비티비는 1999년에 설립되었으며 경기도 성남시에 본사를 두고 있습니다.